Abstract :
An aging population, an increase in lifestyle diseases, and rising consumer demand for healthcare are expected to propel India's pharmaceutical industry, currently valued at about $58 billion, to grow to $120-130 billion by 2030 and $400-450 billion by 2047. With up to 74% of FDI permitted and green field venture procedures made simpler, India is establishing itself as a major location for international investors wishing to grow in the life sciences and healthcare industries.
Keyword :
India; Pharmaceutical industry, Growth, Global supply